BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 24344132)

  • 1. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.
    Schissel SL; Dunsmore SE; Liu X; Shine RW; Perrella MA; Layne MD
    Am J Pathol; 2009 Mar; 174(3):818-28. PubMed ID: 19179605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic carboxypeptidase-like protein enhances adipose tissue stromal progenitor differentiation into myofibroblasts and is upregulated in fibrotic white adipose tissue.
    Jager M; Lee MJ; Li C; Farmer SR; Fried SK; Layne MD
    PLoS One; 2018; 13(5):e0197777. PubMed ID: 29799877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
    Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
    DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
    J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
    Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
    Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IPF pathogenesis is dependent upon TGFβ induction of IGF-1.
    Hernandez DM; Kang JH; Choudhury M; Andrianifahanana M; Yin X; Limper AH; Leof EB
    FASEB J; 2020 Apr; 34(4):5363-5388. PubMed ID: 32067272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-145 regulates myofibroblast differentiation and lung fibrosis.
    Yang S; Cui H; Xie N; Icyuz M; Banerjee S; Antony VB; Abraham E; Thannickal VJ; Liu G
    FASEB J; 2013 Jun; 27(6):2382-91. PubMed ID: 23457217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10).
    White ES; Atrasz RG; Hu B; Phan SH; Stambolic V; Mak TW; Hogaboam CM; Flaherty KR; Martinez FJ; Kontos CD; Toews GB
    Am J Respir Crit Care Med; 2006 Jan; 173(1):112-21. PubMed ID: 16179636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
    Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
    Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
    Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.